Effect of Polypharmacy on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation　― A Sub-Analysis of the ANAFIE Registry ―-Reference-Cited by-同舟云学术

Effect of Polypharmacy on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation　― A Sub-Analysis of the ANAFIE Registry ―

Published:2022-12-23 Issue:1 Volume:87 Page:6-16
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Yamashita Takeshi¹,Akao Masaharu²,Atarashi Hirotsugu³,Ikeda Takanori⁴,Koretsune Yukihiro⁵,Okumura Ken⁶,Shimizu Wataru⁷,Suzuki Shinya¹,Tsutsui Hiroyuki⁸,Toyoda Kazunori⁹,Hirayama Atsushi¹⁰,Yasaka Masahiro¹¹,Yamaguchi Takenori⁹,Teramukai Satoshi¹²,Kimura Tetsuya¹³,Morishima Yoshiyuki¹³,Takita Atsushi¹⁴,Inoue Hiroshi¹⁵

Affiliation:

1. The Cardiovascular Institute

2. Department of Cardiology, National Hospital Organization Kyoto Medical Center

3. AOI Hachioji Hospital

4. Department of Cardiovascular Medicine, Toho University Faculty of Medicine

5. National Hospital Organization Osaka National Hospital

6. Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center

7. Department of Cardiovascular Medicine, Graduate School of Medicine, Nippon Medical School

8. Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University

9. Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center

10. Osaka Police Hospital

11. Department of Cerebrovascular Medicine and Neurology, Cerebrovascular Center, National Hospital Organization Kyushu Medical Center

12. Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine

13. Primary Medical Science Department, Daiichi Sankyo Co., Ltd.

14. Data Intelligence Department, Daiichi Sankyo Co., Ltd.

15. Saiseikai Toyama Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/87/1/87_CJ-22-0170/_pdf

Reference40 articles.

1. 1. Chao TF, Liu CJ, Lin YJ, Chang SL, Lo LW, Hu YF, et al. Oral anticoagulation in very elderly patients with atrial fibrillation: A nationwide cohort study. Circulation 2018; 138: 37–47.

2. 2. Chen N, Alam AB, Lutsey PL, MacLehose RF, Claxton JS, Chen LY, et al. Polypharmacy, adverse outcomes, and treatment effectiveness in patients ≥75 with atrial fibrillation. J Am Heart Assoc 2020; 9: e015089.

3. 3. Mannucci PM, Nobili A. Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI. Intern Emerg Med 2014; 9: 723–734.

4. 4. Shaikh F, Pasch LB, Newton PJ, Bajorek BV, Ferguson C. Addressing multimorbidity and polypharmacy in individuals with atrial fibrillation. Curr Cardiol Rep 2018; 20: 32.

5. 5. Mannucci PM, Nobili A, Pasina L. Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register. Intern Emerg Med 2018; 13: 1191–1200.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary events in elderly patients with non-valvular atrial fibrillation: a prespecified sub-analysis of the ANAFIE registry;Cardiovascular Intervention and Therapeutics;2024-02-13

2. Polypharmacy as New Risk Factor of Major Bleeding in Patients Undergoing Coronary Stent Implantation　― Which Come First, the Chicken or the Egg? ―;Circulation Journal;2023-11-01

3. Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis;Thrombosis and Haemostasis;2023-07-03

4. Polypharmacy in Elderly Patients With Non-Valvular Atrial Fibrillation　― The Trail to Adverse Events ―;Circulation Journal;2022-12-23